Im on my second shipment and I am very happy with the outcome
The results were striking: Weight Loss: At 24 weeks, retatrutide achieved mean weight reductions of 7.2% (1 mg), 12.9% (4 mg), 17.3% (8 mg), and 17.5% (12 mg), compared to 1.6% for placebo
Will definitely be ordering againscolbethRated 5 out of 5May 16, 2026Easy order, fast ship, friendly serviceI was using another vendor but tried Derma Solution
Editors summary Obesity pharmacotherapies typically target short-term regulatory signals such as glucagon-like peptide-1 (GLP-1), because targeting longer-term energy homeostasis pathways, such as through the leptin receptor alone, has proven ineffective
They are not recommended during breast-feeding
Direct Meds and the 2026 Insurance Coverage Loss Landscape Why 24 Million Americans Are Searching for GLP-1 Like Direct Meds Right Now Between 2025 and 2026 an estimated 24 million Americans lost insurance coverage for GLP-1 medications as major pharmacy benefit managers dropped GLP-1s from their formularies and employers restructured health benefits to manage pharmacy cost growth